162 filings
Page 2 of 9
8-K
t68kxgvg7qft nwhvj14
19 Apr 21
Departure of Directors or Certain Officers
4:05pm
8-K
c1ln40r24 rw8a4ih6tu
10 Mar 21
Departure of Directors or Certain Officers
4:08pm
8-K
gqe o8zq7c
31 Dec 20
Entry into a Material Definitive Agreement
4:05pm
8-K
zl147
25 Nov 20
Entry into a Material Definitive Agreement
5:25pm
8-K
0w921zdpplztyl zuo
17 Sep 20
Departure of Directors or Certain Officers
8:05am
8-K
3pfvb0pgterekvvda415
3 Sep 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
oe3wlw7
17 Aug 20
Organovo Announces One-for-Twenty Reverse Stock Split
8:05am
8-K
81vs697yqfa7mayl
15 Jul 20
Entry into a Material Definitive Agreement
8:32am
8-K
t60hj4ngbvpesem5nyx
20 May 20
Departure of Directors or Certain Officers
5:00pm
8-K
qc49ml
8 Apr 20
Organovo Announces Termination of Merger Agreement with Tarveda Therapeutics
4:32pm
8-K
hmei0jvipcf0j aso5
1 Apr 20
Organovo Holdings, Inc. Reminds Stockholders About Adjourned Special Meeting of Stockholders
9:17am
8-K
3xa8n1i
27 Mar 20
Organovo Holdings, Inc. Announces Adjournment of Special Meeting of Stockholders
5:07pm
8-K
c4she
20 Mar 20
Tarveda Therapeutics and SciClone Pharmaceuticals International Establish Licensing Agreement forPEN-866 in Greater China
5:21pm
8-K
0wtlldq9txovhnq8 4gm
29 Jan 20
Entry into a Material Definitive Agreement
6:17am
8-K
6c3nygxosn010r i1mag
30 Dec 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:12am
8-K
uizdokz2
16 Dec 19
Organovo and Tarveda Therapeutics Announce
8:04am
8-K
z0q7s
11 Oct 19
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
cyx857h5yeytg tx
3 Oct 19
Other Events
8:05am
8-K
fxjqwhhn0leze2g2pbn
5 Sep 19
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
9jbzyz3dwntk
7 Aug 19
Organovo to Explore Strategic Alternatives and Implement Restructuring Plan
9:07am